Enalapril Maleate | CAS#76095-16-4 | CAS#75847-73-3 | Angiotensin-Converting Enzyme Inhibitor

Enalapril Maleate
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317770

CAS#: 76095-16-4 (maleate)

Description: Enalapril maleate is an effective and potent angiotensin-converting enzyme inhibitor that is used to treat hypertension and heart failure. The compound has been used to study diabetic angiopathy in diabetic rats and inhibition of ACE in hog plasma. ACE inhibitors disturb the enin-angiotensin- aldosterone system. As a prodrug, enalapril is converted by de-esterification into its active form enalaprilat. Enalaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Enalapril also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.

Chemical Structure

Enalapril Maleate

CAS# 76095-16-4 (maleate)

Product data Instruction

Theoretical Analysis

MedKoo Cat#: 317770
Name: Enalapril Maleate
CAS#: 76095-16-4 (maleate)
Chemical Formula: C24H32N2O9
Exact Mass: 0.00
Molecular Weight: 492.520
Elemental Analysis: C, 58.53; H, 6.55; N, 5.69; O, 29.24

Price and Availability

Size	Price	Availability
1g	USD 265	2 weeks
5g	USD 650	2 weeks
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Related CAS #: 75847-73-3 (free acid) 76095-16-4 (maleate) 149404-21-7 (sodium)

Synonym: Enalapril Maleate; Renitec; Glioten; Vasotec; Baripril; Maleate, Enalapril; MK 421; MK-421; MK421; Renitec; Renitek;

IUPAC/Chemical Name: (Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid

InChi Key: OYFJQPXVCSSHAI-QFPUQLAESA-N

InChi Code: InChI=1S/C20H28N2O5.C4H4O4/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25;5-3(6)1-2-4(7)8/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,16-,17-;/m0./s1

SMILES Code: CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O.C(=C\C(=O)O)\C(=O)O

Appearance: White to off-white crystalline powder.

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:

Product Data

Instruction:

View handling instruction

Biological target:	Enalapril (maleate) (MK-421 (maleate)), the active metabolite of enalapril, is an angiotensin-converting enzyme (ACE) inhibitor.
In vitro activity:	Enalapril significantly inhibited LPS-induced IκBα phosphorylation/degradation, NF-κB binding activity, and pro-inflammatory cytokine production in both IEC and peritoneal macrophages. The administration of enalapril significantly reduced the severity of colitis, as assessed based on histology in both murine colitis models. Furthermore, in colon tissue, the up-regulation of IκBα phosphorylation with colitis induction was attenuated in enalapril-treated mice. Reference: Life Sci. 2014 Jan 24;95(1):29-39. https://pubmed.ncbi.nlm.nih.gov/24239644/
In vivo activity:	Enalapril (ENAL) was efficient in decreasing steatosis in mice fed a hyperlipidemic diet, histological observation of hepatic tissue showed a considerable increase of dispersed fat droplets in the liver of HF animals and a statistically significant lower mean in the HF + ENAL group (p = 0.0123) (Fig. 3D; E). Reference: Prostaglandins Other Lipid Mediat. 2021 Feb;152:106501. https://pubmed.ncbi.nlm.nih.gov/33049402/

Solubility Data

	Solvent	Max Conc. mg/mL	Max Conc. mM
Solubility
	DMSO	37.5	76.14
	DMF	15.0	30.46
	Ethanol	0.3	0.51
	PBS (pH 7.2)	1.0	2.03
	Water	33.3	67.67

Preparing Stock Solutions

The following data is based on the product molecular weight 492.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:	1. Laham HZ, Khabour OF, Alzoubi KH, Sadiq MF. Enalapril protect human lymphocytes from genotoxicity of Hydrochlorothiazide. Pak J Pharm Sci. 2019 Nov;32(6):2667-2671. PMID: 31969300. 2. Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Life Sci. 2014 Jan 24;95(1):29-39. doi: 10.1016/j.lfs.2013.11.005. Epub 2013 Nov 15. PMID: 24239644. 3. Moraes DS, Lelis DF, Andrade JMO, Meyer L, Guimarães ALS, De Paula AMB, Farias LC, Santos SHS. Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice. Prostaglandins Other Lipid Mediat. 2021 Feb;152:106501. doi: 10.1016/j.prostaglandins.2020.106501. Epub 2020 Oct 10. PMID: 33049402. 4. Ma H, Zhang Q, Shi J, Gao Y, Sun C, Zhang W. Enalapril inhibits inflammatory osteolysis induced by wear debris in a mouse model. J Int Med Res. 2020 Jun;48(6):300060520931612. doi: 10.1177/0300060520931612. PMID: 32552231; PMCID: PMC7303775.
In vitro protocol:	1. Laham HZ, Khabour OF, Alzoubi KH, Sadiq MF. Enalapril protect human lymphocytes from genotoxicity of Hydrochlorothiazide. Pak J Pharm Sci. 2019 Nov;32(6):2667-2671. PMID: 31969300. 2. Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Life Sci. 2014 Jan 24;95(1):29-39. doi: 10.1016/j.lfs.2013.11.005. Epub 2013 Nov 15. PMID: 24239644.
In vivo protocol:	1. Moraes DS, Lelis DF, Andrade JMO, Meyer L, Guimarães ALS, De Paula AMB, Farias LC, Santos SHS. Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice. Prostaglandins Other Lipid Mediat. 2021 Feb;152:106501. doi: 10.1016/j.prostaglandins.2020.106501. Epub 2020 Oct 10. PMID: 33049402. 2. Ma H, Zhang Q, Shi J, Gao Y, Sun C, Zhang W. Enalapril inhibits inflammatory osteolysis induced by wear debris in a mouse model. J Int Med Res. 2020 Jun;48(6):300060520931612. doi: 10.1177/0300060520931612. PMID: 32552231; PMCID: PMC7303775.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Aygen B, Kucuksu M, Aydin S, Ozercan IH. Effect of enalapril maleate on
ghrelin levels in metabolic syndrome in rats. Peptides. 2015 May;67:39-44. doi:
10.1016/j.peptides.2015.03.002. Epub 2015 Mar 14. PubMed PMID: 25784288.

2: de Oliveira AP, Cunha TA, Serpa RC, Taveira SF, Lima EM, Almeida Diniz DG, de
Freitas LA, Marreto RN. Improvement of enalapril maleate chemical stability by
high shear melting granulation. Pharm Dev Technol. 2014 Sep 18:1-7. [Epub ahead
of print] PubMed PMID: 25231642.

3: Ramírez-Rigo MV, Olivera ME, Rubio M, Manzo RH. Enhanced intestinal
permeability and oral bioavailability of enalapril maleate upon complexation with
the cationic polymethacrylate Eudragit E100. Eur J Pharm Sci. 2014 May
13;55:1-11. doi: 10.1016/j.ejps.2014.01.001. Epub 2014 Jan 20. PubMed PMID:
24456933.

4: Chen J, Zhang LH, Xu RJ, Bu NJ, Zhang L. Proposal of a new degradation
mechanism of enalapril maleate and improvement of enalapril maleate stability in
tablet formulation with different stabilizers. Pharmazie. 2014 Apr;69(4):277-80.
PubMed PMID: 24791591.

5: Matsuura-Hachiya Y, Arai KY, Ozeki R, Kikuta A, Nishiyama T.
Angiotensin-converting enzyme inhibitor (enalapril maleate) accelerates recovery
of mouse skin from UVB-induced wrinkles. Biochem Biophys Res Commun. 2013 Dec
6;442(1-2):38-43. doi: 10.1016/j.bbrc.2013.10.162. Epub 2013 Nov 8. PubMed PMID:
24216112.

6: Vehovec T, Gartner A, Planinšek O, Obreza A. Influence of different types of
commercially available microcrystalline cellulose on degradation of perindopril
erbumine and enalapril maleate in binary mixtures. Acta Pharm. 2012
Dec;62(4):515-28. doi: 10.2478/v10007-012-0039-5. PubMed PMID: 23333887.

7: Hartung A, Knoell M, Schmidt U, Langguth P. Relevance of air-to-liquid mass
ratio effect on final granule properties of an Enalapril maleate formulation.
Drug Dev Ind Pharm. 2012 Jan;38(1):12-8. doi: 10.3109/03639045.2011.589451. Epub
2011 Jul 1. PubMed PMID: 21721850.

8: Bibi R, Naqvi BS, Shoaib MH, Rahim N. Design and evaluation of a new
formulation of enalapril maleate tablet. Pak J Pharm Sci. 2011 Apr;24(2):211-5.
PubMed PMID: 21454172.

9: Semalty A, Semalty M, Nautiyal U. Formulation and evaluation of mucoadhesive
buccal films of enalapril maleate. Indian J Pharm Sci. 2010 Sep;72(5):571-5. doi:
10.4103/0250-474X.78522. PubMed PMID: 21694987; PubMed Central PMCID: PMC3116300.

10: Toporisic R, Mlakar A, Hvala J, Prislan I, Zupancic-Kralj L. Identification
of new impurities of enalapril maleate on oxidation in the presence of magnesium
monoperoxyphthalate. J Pharm Biomed Anal. 2010 Jun 5;52(2):294-9. doi:
10.1016/j.jpba.2009.12.018. Epub 2009 Dec 29. PubMed PMID: 20122808.

11: Loftsson T, Thorisdóttir S, Fridriksdóttir H, Stefánsson E. Enalaprilat and
enalapril maleate eyedrops lower intraocular pressure in rabbits. Acta
Ophthalmol. 2010 May;88(3):337-41. doi: 10.1111/j.1755-3768.2008.01495.x. Epub
2009 Apr 29. PubMed PMID: 19432862.

12: Lopes RA, Neves Fde A. Meta-analysis for bioequivalence studies:
interchangeability of generic drugs and similar containing Hydrochlorothiazide is
possible but not with Enalapril Maleate. J Bras Nefrol. 2010
Apr-Jun;32(2):173-81. English, Portuguese. PubMed PMID: 21103677.

13: Nair AB, Vyas H, Kumar A. Controlled release matrix uncoated tablets of
enalapril maleate using hpmc alone. J Basic Clin Pharm. 2010 Mar;1(2):71-5. Epub
2010 May 15. PubMed PMID: 24825968; PubMed Central PMCID: PMC3979173.

14: Al-Arfaj NA, Al-Abdulkareem EA, Aly FA. Determination of enalapril maleate
and atenolol in their pharmaceutical products and in biological fluids by
flow-injection chemiluminescence. Luminescence. 2009 Nov-Dec;24(6):422-8. doi:
10.1002/bio.1129. PubMed PMID: 19455718.

15: Sosnowska K, Winnicka K, Czajkowska-Kośnik A. Stability of extemporaneous
enalapril maleate suspensions for pediatric use prepared from commercially
available tablets. Acta Pol Pharm. 2009 May-Jun;66(3):321-6. PubMed PMID:
19645333.

16: Zhao F, Li JP, Wang SY, Guan DM, Ge JB, Hu J, Wang YN, Zhang FM, Huo Y. [The
effect of baseline homocysteine level on the efficacy of enalapril maleate and
folic acid tablet in lowering blood pressure and plasma homocysteine]. Zhonghua
Yi Xue Za Zhi. 2008 Nov 18;88(42):2957-61. Chinese. PubMed PMID: 19080072.

17: Yamane T, Fujii Y, Orito K, Osamura K, Kanai T, Wakao Y. Comparison of the
effects of candesartan cilexetil and enalapril maleate on right ventricular
myocardial remodeling in dogs with experimentally induced pulmonary stenosis. Am
J Vet Res. 2008 Dec;69(12):1574-9. doi: 10.2460/ajvr.69.12.1574. PubMed PMID:
19046003.

18: Baraka MM, El-Sadek M, Moussa EM, Abd-Alaty NM. Spectrophotometric and atomic
absorption determination of ramipril, enalapril maleate and fosinopril through
ternary complex formation with molybdenum (V)-thiocyanate (Mo(V)-SCN). Chem Pharm
Bull (Tokyo). 2008 Nov;56(11):1521-7. PubMed PMID: 18981600.

19: Lima DM, dos Santos LD, Lima EM. Stability and in vitro release profile of
enalapril maleate from different commercially available tablets: possible
therapeutic implications. J Pharm Biomed Anal. 2008 Aug 5;47(4-5):934-7. doi:
10.1016/j.jpba.2008.02.030. Epub 2008 Mar 4. PubMed PMID: 18472382.

20: Zhang BQ, Huang YS, Zhang JP, Zhang DX, Dang YM, Wang G, Hu JY, Lei ZY, Xiao
R. [Protective effects of administration of enalapril maleate on rat myocardial
damage in early stage of burns]. Zhonghua Shao Shang Za Zhi. 2007
Oct;23(5):335-8. Chinese. PubMed PMID: 18396757.

Your view history

Enalapril Maleate featured